Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Duloxetine HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

121 API Suppliers, 45 USDMF, 34 CEP/COS, 12 JDMF, 21 EU WC, 26 KDMF, 18 NDC API, 57 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

INTERMEDIATES

32 Intermediate Suppliers

32 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

708 FDF Dossiers, 98 FDA Orange Book, 396 Europe, 39 Canada, 21 Australia, 30 South Africa, 124 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

RELATED EXCIPIENT COMPANIES

3 Evonik, 1 Rochem International Inc, 16 SPI Pharma, 17 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 35 BASF, 1 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 9 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 5 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

70 Coating Systems & Additives, 70 Fillers, Diluents & Binders, 36 Solubilizers, 35 Disintegrants & Superdisintegrants, 33 Controlled & Modified Release, 33 Direct Compression, 29 Thickeners and Stabilizers, 28 Granulation, 22 Topical, 21 Taste Masking, 20 Parenteral, 19 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 11 Co-Processed Excipients, 9 Empty Capsules, 9 Emulsifying Agents, 7 API Stability Enhancers, 6 Rheology Modifiers, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 59 News #PharmaBuzz

GLOBAL SALES INFORMATION

21 US Medicaid Prescriptions, 115 Regulatory FDF Prices, 15 Annual Reports

MARKET PLACE

24 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 11 USP, 15 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Egis Pharmaceuticals PLC	Hungary	EGIS Pharmaceuticals PLC Budapest HU	CEP 2023-144 - Rev 00	Duloxetine hydrochloride	2024-12-19	Valid	Chemical		2594
29/11/2025	Moehs Iberica	Spain	Moehs Iberica S.L. Rubi ES	CEP 2012-319 - Rev 01	Duloxetine hydrochloride, Milled, micronised	2024-06-21	Valid	Chemical		2594

Duloxetine HCl

Duloxetine HCl

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

121 API Suppliers

45 USDMF

34 CEP/COS

12 JDMF

21 EU WC

26 KDMF

18 NDC API

57 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

71 Drugs in Development

INTERMEDIATES

32 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

708 FDF Dossiers

98 FDA Orange Book

396 Europe

39 Canada

21 Australia

30 South Africa

124 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

RELATED EXCIPIENT COMPANIES

3 Evonik

1 Rochem International Inc

16 SPI Pharma

17 DKSH

8 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

2 Pfanstiehl

3 Kirsch Pharma

4 ACG Worldwide

6 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

35 BASF

1 Clariant

13 Corel Pharma Chem

3 DFE Pharma

2 Esteem Industries

2 Finar

14 Gangwal Chemicals

9 Ideal Cures

4 Ingredion Pharma Solutions

22 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

11 Roquette

14 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

5 Sigachi Industries

2 Silverline Chemicals

4 The Dow Chemical Company

2 Ulanqab Kema New Material